Evaluating Therapeutic Response to Novo-TTF

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

June 30, 2023

Study Completion Date

December 31, 2023

Conditions
Glioblastoma Multiforme
Interventions
DEVICE

Novo-TTF

Procedures: MRI and advanced MRI sequence Advanced brain MRI's with special sequences will be obtained. First MRI prior to starting Novo-TTF therapy, second MRI up to 2-3 weeks after beginning therapy, third MRI up to 2 months from starting treatment and the last MRI up to 4 months after starting treatment.

Trial Locations (1)

19104

University Of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT02441322 - Evaluating Therapeutic Response to Novo-TTF | Biotech Hunter | Biotech Hunter